Radioassays for quantitation of intact complement proteins C2 and B in human serum.

[1]  J. Kearney,et al.  Probing functional sites on complement protein B with monoclonal antibodies. Evidence for C3b-binding sites on Ba. , 1987, Journal of immunology.

[2]  C. Sprung,et al.  Complement activation in septic shock patients , 1986, Critical care medicine.

[3]  H. Colten,et al.  Regulation of class III major histocompatibility complex gene products by interleukin-1. , 1986, Science.

[4]  H. Colten,et al.  gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes. , 1985, The Journal of biological chemistry.

[5]  J. Kearney,et al.  Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay. , 1984, Journal of immunological methods.

[6]  T. Yanase,et al.  Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus. , 1983, Clinical and experimental immunology.

[7]  D. Isenman.  Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies. , 1983, The Journal of biological chemistry.

[8]  M. Rodrigo,et al.  Complement activation in septic shock due to gramnegative and gram‐positive bacteria , 1982, Critical care medicine.

[9]  T. Out,et al.  A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo. , 1981, Journal of immunology.

[10]  J. Kearney,et al.  Cross-reactivity between C-reactive protein and idiotypic determinants on A phosphocholine-binding murine myeloma protein , 1981, The Journal of experimental medicine.

[11]  J. Volanakis,et al.  Amino-terminal sequence of human factor B of the alternative complement pathway and its cleavage fragments, Ba and Bb. , 1980, Biochemistry.

[12]  R. Johnston,et al.  Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. , 1978, The New England journal of medicine.

[13]  E. Lewis,et al.  Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis. , 1978, Clinical and experimental immunology.

[14]  P. A. Peterson,et al.  Chemical characterization of human factor B of the alternate pathway of complement activation. , 1977, Biochemistry.

[15]  R. Stroud,et al.  Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Schur,et al.  Inherited deficiency of the second component of complement. Rheumatic disease associations. , 1976, The Journal of clinical investigation.

[17]  G. Füst,et al.  Activation of the complement system during infections due to gram-negative bacteria. , 1976, Clinical immunology and immunopathology.

[18]  P. Schur,et al.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. , 1975, The New England journal of medicine.

[19]  P. Schur,et al.  Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. , 1972, The New England journal of medicine.

[20]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[21]  M. Steinbuch,et al.  The isolation of IgG from mammalian sera with the aid of caprylic acid. , 1969, Archives of biochemistry and biophysics.

[22]  M. Klemperer.  Hereditary deficiency of the second component of complement in man: an immunochemical study. , 1969, Journal of immunology.

[23]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[24]  J. Volanakis,et al.  Carbohydrate composition of the second, third and fifth components and factors B and D of human complement. , 1985, Molecular immunology.

[25]  H. Rapp,et al.  Molecular Basis of Complement Action , 1970 .